ストックスクリーナーアプリを入手
7.4236
4.67%
0.3309
アフターアワーズ：
7.50
0.0764
+1.03%
Leverage Shares 2 X Long Grab Daily Etf (GRAG) 最新ニュース
Critical Limb Ischemia Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Baxter, Ixaka, Hemostemix Inc., Caladrius Biosciences, Vericel Corporation, Helixmith, Lifecells, LLC - Barchart.com
Chronic Wounds Market: Accelerating Growth and Pipeline Impact by 2034 – DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE - Barchart.com
An underwater bus in Havana becomes the ride that matters during Cuba's fuel crisis - Barchart
GRAG Options Volatility — NASDAQ:GRAG - TradingView — Track All Markets
GRAG Options Chain — NASDAQ:GRAG - TradingView — Track All Markets
D-Wave Quantum has been cut in halfcan a leveraged ETF help bulls? - MSN
How the Strait of Hormuz ping pong ball is affecting commodity prices from soup to nuts - Barchart.com
Best Oil ETFs in Canada for 2026 - Stocktrades
Stock List: Research Stocks from Around the World - GuruFocus
Fabry Disease Market Set for Robust Growth by 2034, Driven by Gene Therapy Breakthroughs and Expanding Pipeline from Sangamo, Sanofi, Amicus & Emerging Innovators | DelveInsight - Barchart.com
Non Tuberculous Mycobacterial Infections Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharmaceuticals - Barchart.com
Exocrine Pancreatic Insufficiency Market: Expanding Revenue Landscape to 2034 – DelveInsight | First Wave BioPharma, Abbott Products, AAIPharma, Solvay Pharmaceuticals, Abbott, Forest Laboratories - Barchart.com
K2 Gold Receives Positive Record of Decision for Exploration Drilling at the Mojave Project, California - Barchart
Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - Barchart.com
Stream if You Want to Go Faster: Netflix's New $120 Target - Barchart.com
Systemic Sclerosis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Boehringer Ingelheim, Roche, Zenyaku Kogyo, Chugai Pharma, Kyowa Kirin, GSK, AstraZeneca, Amgen - Barchart.com
Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro - Barchart
7 Best Leveraged ETFs for April 2026 - NerdWallet
Best Easter Products to Sell 2026: 9 Profitable Easter Crafts & Personalized Gift Ideas for Small Business - Barchart.com
UK gathers more than 40 countries to press Iran to reopen the Strait of Hormuz - Barchart.com
Conservatives call for lower gas tax and cuts to 'wasteful spending' to pay for it - Barchart
US-Europe rift widens as Trump lashes out at NATO allies over Mideast war - Barchart
Advocacy groups urge YouTube to protect kids from 'AI slop' videos - Barchart.com
Down 37% in 2026, Dan Ives Says You Should Buy the Dip in Zscaler Stock - Barchart.com
Energy Prices Could Soon ‘Skyrocket.’ Why Cheniere Is One of the Top-Rated Stocks to Buy Now. - Barchart
D-Wave Quantum Has Been Cut in Half—Can a Leveraged ETF Help Bulls? - MarketBeat
Cardi B and Steph Curry earn Webby Award nominations, along with Sydney Sweeney's bathwater - Barchart.com
Is the Explosion of Single-Stock ETFs an Opportunity or a Danger? - MarketBeat
Arm Is Making ‘Bold Moves’ with New In-House Chips and Wall Street Loves It. Why Needham Says You Should Buy ARM Stock Here. - Barchart.com
ROYAL CARIBBEAN'S HERO OF THE SEAS INTRODUCES THE NEXT EVOLUTION OF FAMILY VACATION EXPERIENCES - Barchart.com
Judge won't block meeting that could exempt Gulf drilling from Endangered Species Act - Barchart
10 Inverse ETFs That Gain in a Bear Market - U.S. News Money
Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - Barchart.com
Stock Index Futures Rally as Oil Prices Tumble on U.S.-Iran Talks - Barchart.com
Muscle Invasive Bladder Cancer Market Set for Strong Growth Through 2034, Driven by Expanding Pipeline and Innovation | DelveInsight - Barchart
Sickle Cell Disease Market: Investment-Ready Growth Trends to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis - Barchart
The CLIF Brand Expands Energy Portfolio with New Energy Bites and Limited-Edition Chocolate Berry Energy Bar - Barchart.com
Tradr 2X Long ASTS Daily ETF ETF Price, Holdings, & News (BATS:ASTX) - MarketBeat
Best-Performing Leveraged ETFs of Last Week - Yahoo Finance
Walmart v.s Costco: Which Is the Better Dividend Stock in 2026? - Barchart.com
UPDATE -- Tidal Financial Group and Defiance ETFs Announce Reverse Stock Splits for Select ETFs - Yahoo Finance
This Steel Stock Just Hiked its Dividend by 6%, Is it a Buy Now? - Barchart.com
Fabry Disease Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, AVROBIO, 4D Molecular Therapeutics - Barchart.com
Stitch Fix (SFIX) To Report Earnings Tomorrow: Here Is What To Expect - Barchart.com
FOMO Trade: Can Grab Holdings Limited Equity Warrant beat the S P 5002026 Movers & Verified Momentum Stock Ideas - baoquankhu1.vn
Stocks in play: GoldHaven Resources Corp - Barchart.com
Glaucoma Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire Pharma, Kowa - Barchart.com
As Marvell Breaks Through Key Resistance Levels, Should You Chase the Rally in MRVL Stock? - Barchart.com
6 Best Defense ETFs to Buy in 2026 - The Motley Fool
Leverage Shares 2X Long GRAB Daily ETF (GRAG.US) Latest News & Headlines - Longbridge
Steel Stocks Have Been Flying Higher. The Chart Says Another Monster Move Could Be Coming. - Barchart
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 – DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, AKARI Therapeutics, AstraZeneca - Barchart.com
Best Buy (BBY) Reports Earnings Tomorrow: What To Expect - Barchart.com
Viking (VIK) Q4 Earnings Report Preview: What To Look For - Barchart
What To Expect From MongoDB’s (MDB) Q4 Earnings - Barchart.com
Uber Air Is Officially Here. Does That Make Uber Stock a Buy on Flying Car Dreams? - Barchart.com
0.17%
大文字化:
|
ボリューム (24 時間):